| For: | Ma HN, Cao KS, Liu YM, Chen C, Zhang H, Tang FS. Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment. World J Gastroenterol 2025; 31(10): 102580 [PMID: 40093664 DOI: 10.3748/wjg.v31.i10.102580] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i10/102580.htm |
| Number | Citing Articles |
| 1 |
Zhen-Yu Xu, Cai-Liang Qiu, Min Zhang, Jin-Qing Liu, Zhi-Hao Zeng. Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch. World Journal of Gastroenterology 2025; 31(26): 109285 doi: 10.3748/wjg.v31.i26.109285
Abstract(281) |
Core Tip(269) |
Full Article(HTML)(1630)
|
Full Article (PDF)-1884K(146)
|
Full Article with Cover (PDF)-2247K(82)
|
Full Article (XML)-95K(60)
|
Audio-238K(30)
|
Peer-Review Report-331K(75)
|
Answering Reviewers-565K(70)
|
Supplementary Material-101K(64)
|
Times Cited (2)
|
Total Visits (2285)
|
Open
|